SLNO Operating Expenses

Soleno Therapeutics Inc · Operating Expenses

SLNO logo

SLNO Operating Expenses

Latest reported$61.64M
SLNO Quarterly Operating Expenses ($1.12M → $61.64M)
High-resolution chart · PNG

SLNO operating expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Soleno Therapeutics Inc Operating Expenses — Quarterly (USD)
Period endingOperating Expenses (USD)
61,643,000
50,436,000
42,772,000
38,486,000
45,743,000
59,116,000
80,212,000
22,737,000
23,475,000
13,910,000
10,382,000
8,623,000
8,469,000
5,610,000
6,235,000
6,779,000
5,773,000
3,001,000
8,286,000
11,085,000
-9,156,000
7,957,000
7,857,000
11,193,000
-9,282,000
6,880,000
6,105,000
5,440,000
4,772,000
3,557,000
3,650,000
3,480,000
3,047,000
2,707,123
2,689,000
3,169,000
2,266,000
3,017,597
2,871,000
3,413,000
4,249,000
3,491,618
3,219,000
3,054,000
2,430,000
1,845,729
1,323,000
1,307,000
684,488
559,783
993,000
1,176,047
1,118,777
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.